Universität zu Köln

Prinz, Lars Fabian ORCID: 0000-0002-3580-7627, Riet, Tobias ORCID: 0000-0002-8211-7071, Neureuther, Daniel Felix, Lennartz, Simon ORCID: 0000-0001-7202-398X, Chrobok, Danuta, Hübbe, Hanna, Uhl, Gregor ORCID: 0000-0003-3792-1076, Riet, Nicole, Hofmann, Petra, Hösel, Marianna, Simon, Adrian Georg ORCID: 0000-0002-2709-863X, Tetenborg, Luis, Segbers, Paul, Shimono, Joji, Gödel, Philipp ORCID: 0000-0001-7887-8313, Balke-Want, Hyatt ORCID: 0000-0002-5963-7626, Flümann, Ruth ORCID: 0000-0002-7147-7557, Knittel, Gero, Reinhardt, Hans Christian, Scheid, Christoph ORCID: 0009-0007-6539-226X, Büttner, Reinhard ORCID: 0000-0001-8806-4786, Chapuy, Björn, Ullrich, Roland Tillmann, Hallek, Michael ORCID: 0000-0002-7425-4455 and Chmielewski, Markus Martin ORCID: 0000-0001-9348-5219 (2024). An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL. Cell Reports Medicine, 5 (2). pp. 1-26. Elsevier. ISSN 2666-3791

Ullrich, Roland Tillmann (2011). Molecular imaging for the quantitative assessment of tumor proliferation, progression and the early assessment of molecular targeted treatment response. PhD thesis, Universität zu Köln.